GLP3-R —10 Vials

GLP-3 R (Reta) is an advanced, next-generation research peptide designed to engage three critical metabolic pathways by acting as a multi-receptor agonist of GLP-1, GIP, and glucagon receptors. This unique triple-action mechanism has positioned Reta as one of the most compelling compounds currently being studied in the field of metabolic health and obesity research. By simultaneously supporting appetite regulation, enhancing energy expenditure, and improving insulin sensitivity, GLP-3 R demonstrates a comprehensive approach to metabolic optimization rather than targeting a single pathway. Early clinical research has reported substantial reductions in body mass, alongside meaningful improvements in glycemic control and metabolic markers. As interest grows in more efficient and holistic metabolic therapies, Reta stands out as a promising breakthrough peptide under investigation, offering researchers a cutting-edge tool for exploring the future of weight management and metabolic disorder treatment.